Granules India Limited (IN:GRANULES)
:GRANULES
GRANULES Stock Chart & Stats
₹615.10
₹1.80(0.30%)
At close: 4:00 PM EST
₹615.10
₹1.80(0.30%)
Day’s Range― - ―
52-Week Range₹412.05 - ₹640.00
Previous CloseN/A
Volume528.44K
Average Volume (3M)56.05K
Market Cap
₹149.00B
Enterprise Value₹168.26B
Total Cash (Recent Filing)₹6.26B
Total Debt (Recent Filing)₹18.07B
Price to Earnings (P/E)24.2
Beta1.13
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)6.20
Shares Outstanding242,668,720
10 Day Avg. Volume60,875
30 Day Avg. Volume56,048
Financial Highlights & Ratios
PEG Ratio0.99
Price to Book (P/B)3.15
Price to Sales (P/S)2.61
P/FCF Ratio60.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹682.00Price Target Upside10.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)32.35
Revenue Forecast (FY)₹61.25B
Bulls Say, Bears Say
Bulls Say
Diversified Business ModelGranules' integrated presence across APIs, PFIs and finished dosage formulations gives durable revenue diversification and vertical capture of manufacturing margins. Serving regulated markets raises customer stickiness and barriers to entry, supporting steady volumes and resilience over months.
Strong Cash GenerationRobust operating cash flow and improving free cash flow enhance Granules' ability to fund capex, service debt and reinvest in regulated-market capabilities. Reliable cash conversion supports operational stability and flexibility in allocating capital over a 2–6 month horizon and beyond.
High Profitability And ROEConsistently high gross margins and strong return on equity indicate effective manufacturing scale, cost control and profitable product mix. This profit durability underpins long‑term cash generation and provides buffer against margin pressure in commoditized segments.
Bears Say
Moderate LeverageA moderately high debt-to-equity position increases interest expense and reduces financial flexibility. Over a multi-month horizon higher leverage can constrain investment choices, heighten refinancing risk if rates rise, and limit the firm's ability to scale capacity quickly.
Revenue VolatilityHistorical fluctuations and a recent slight revenue decline point to exposure to product mix shifts and demand swings. Persistent volatility complicates forecasting, capital allocation and margin planning, making earnings less predictable across the next several quarters.
Exposure To Commoditized GenericsSignificant API and bulk-product sales subject the firm to intense price competition and volume cyclicality. Commodity dynamics reduce pricing power and can compress margins over time unless offset by scale, differentiation or shift to higher-value regulated formulations.
Granules India Limited News
GRANULES FAQ
What was Granules India Limited’s price range in the past 12 months?
Granules India Limited lowest stock price was ₹412.05 and its highest was ₹640.00 in the past 12 months.
What is Granules India Limited’s market cap?
Granules India Limited’s market cap is ₹149.00B.
When is Granules India Limited’s upcoming earnings report date?
Granules India Limited’s upcoming earnings report date is May 20, 2026 which is in 43 days.
How were Granules India Limited’s earnings last quarter?
Granules India Limited released its earnings results on Jan 23, 2026. The company reported ₹6.2 earnings per share for the quarter, beating the consensus estimate of ₹5.85 by ₹0.35.
Is Granules India Limited overvalued?
According to Wall Street analysts Granules India Limited’s price is currently Undervalued.
Does Granules India Limited pay dividends?
Granules India Limited pays a Annually dividend of ₹1.5 which represents an annual dividend yield of 0.24%. See more information on Granules India Limited dividends here
What is Granules India Limited’s EPS estimate?
Granules India Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Granules India Limited have?
Granules India Limited has 242,668,720 shares outstanding.
What happened to Granules India Limited’s price movement after its last earnings report?
Granules India Limited reported an EPS of ₹6.2 in its last earnings report, beating expectations of ₹5.85. Following the earnings report the stock price went down -1.094%.
Which hedge fund is a major shareholder of Granules India Limited?
Currently, no hedge funds are holding shares in IN:GRANULES
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Granules India Limited
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.
GRANULES Stock 12 Month Forecast
Average Price Target
₹682.00
▲(10.88% Upside)
Technical Analysis
Alembic Pharmaceuticals Limited
―
Aurobindo Pharma Ltd
―
Cipla Ltd
―
Glenmark Pharmaceuticals Limited
―
Sanofi India Limited
―